IMPACT FACTOR: 1.2
Short Name: Neurol Neurol Sci Open Access
ISSN: 2641-0362
Publisher: MedDocs Publishers LLC
Spinal Cord Injury (SCI) remains a devastating neurological disorder that frequently results in permanent motor, sensory, and autonomic impairment. Despite advances in surgical stabilization and neurorehabilitation strategies, effective regenerative therapies capable of restoring neurological function remain limited.
The introduction of the term Morning Headache (MH) is ascribed to Guilleminault et al. dating back to the late 1970's, when these authors first described that a significant proportion (36%) of patients with Sleep Apnea Syndrome (SAS) complained a diffuse headache upon waking, and named the condition as morning headache [1,2].
Peripheral nerve injury is the predominant cause of disability in individuals of working age. To date, the only treatment for peripheral nerve injury is surgical intervention; nevertheless, postoperative outcomes frequently fail to meet expectations. This review provided a comprehensive role of umbilical cord derived from Mesenchymal Stem Cell (MSC) and adipose tissue on nerve growth factor in peripheral nerve injury.
Neuroinflammation is a prominent cause of multiple sclerosis pathogenesis. As a result, a greater understanding of the role played by neuroinflammation in these devastating conditions development should be deemed necessary for the design of effective new therapies.
The relevance of fluid shifts related to the impaired competence of the blood brain barrier in the absence of traumatic brain injury may be under-recognized and the clinical impact of shifts of fluids in the brain in the context of an acute systemic illness may pose a challenge to neurologists, intensivists and radiologists.
We always work towards offering the best to you. For any queries, please feel free to get in touch with us. Also you may post your valuable feedback after reading our journals, ebooks and after visiting our conferences.
